Figure 3: ECFP-based screening of Aβ aggregation inhibitors in living E. coli cells. | Nature Communications

Figure 3: ECFP-based screening of Aβ aggregation inhibitors in living E. coli cells.

From: Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer’s disease

Figure 3

A to G: control (without POMs), Dawson-POM, Dawson-POM-Ni, Dawson-POM-Mn, Dawson-POM-Co, Dawson-POM-Cu, Dawson-POM-Fe. % ALC/CFP means percentage of the fluorescence intensity of E. coli cells expressing ALC divided by the fluorescence of E. coli cells expressing CFP. Data represent the average of three replicate experiments and the error bars indicate the ±s.d.

Back to article page